abstract |
The present invention relates to lipid-substituted amino 1,2- and 1,3-diol compounds, pharmaceutical compositions comprising these compounds, and the use of these compounds in the treatment of inflammatory diseases and certain neurological processes associated with inflammatory signaling processes Systemic diseases, including but not limited to the use of misfolded proteins in methods of treatment or in medicine. |